CBP/p300 drives the differentiation of Regulatory T cells through transcriptional and non-transcriptional mechanisms

Cancer Research Online First Articles by Joseph Castillo, Esther Wu, Christo.. - 2h ago Preview

 
 
• AUTO POST
 
• SAVE TO EVERNOTE

Regulatory T cells (Tregs) are immunosuppressive and negatively impact response to cancer immunotherapies. CREB-binding protein (CBP) and p300 are closely related acetyltransferases and transcriptional coactivators. Here, we evaluate the mechanisms by which CBP/p300 regulate Treg differentiation and the consequences of CBP/p300 loss-of-function mutations in follicular lymphoma. Transcriptional and epigenetic profiling identified a cascade of transcription factors essential for Treg differentiation. Mass spectrometry analysis showed that CBP/p300 acetylates prostacyclin synthase, which regulates Treg differentiation by altering pro-inflammatory cytokine secretion by T and B cells. Reduced Treg presence in tissues harboring CBP/p300 loss-of-function mutations was observed in follicular lymphoma. Our findings provide novel insights into the regulation of Treg differentiation by CBP/p300 with potential clinical implications on alteration of the immune landscape.